News & Updates
Filter by Specialty:
Berdazimer gel reduces molluscum contagiosum lesions in children
An analysis of three randomized controlled trials (RCTs) has shown the efficacy and safety of berdazimer gel, a topical, antiviral, nitric oxide-releasing medication, in the treatment of molluscum contagiosum (MC) lesions in patients aged 6 months and older. Application-site pain and erythema are the most common adverse events (AEs) related to treatment.
Berdazimer gel reduces molluscum contagiosum lesions in children
22 Jan 2024Is night-time better than morning dosing of antihypertensives?
Bedtime dosing of antihypertensive medication is neither better nor worse than morning dosing when it comes to the subsequent risk of all-cause or cardiovascular mortality, according to a study.
Is night-time better than morning dosing of antihypertensives?
22 Jan 2024Capivasertib fits the bill for HR+, HER2– ABC
Capivasertib, when added to fulvestrant, prolonged progression-free survival (PFS) by 4.1 months in an analysis of Chinese patients with hormone receptor–positive (HR+), HER2-negative (HER2– ABC) advanced breast cancer (ABC) whose disease had progressed on aromatase inhibitor, with or without a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor in the phase III CAPItello-291 trial.